PARIS — Citing clinical results they qualified as "fabulous," and "impressive," two key opinion leaders affiliated with Edwards Lifesciences (Irvine, California) are calling for an end to the dominance of open-chest surgery as the gold standard for treating patients with stenosis of the aortic valve.